Overview

This comprehensive volume offers a complete and up-to-date overview of dermatologic therapeutics, including the latest advancements in the field. Each drug is presented in a concise and structured format—covering its introduction, mechanism of action, pharmacokinetics, indications, contraindications, clinical uses, and adverse effects. Special attention is given to its use in pregnancy, lactation, as well as in pediatric and geriatric populations. Focusing on topical therapies, this book serves as an essential resource for dermatologists, students, and healthcare professionals. Thoughtfully designed flow diagrams throughout the text enhance understanding and bring clarity to complex concepts, reflecting the author’s practical insights and clinical experience. This is volume 3 of the set of three volumes.

Full Product Details

Author:   Aditya Kumar Bubna
Publisher:   Springer Verlag, Singapore
Imprint:   Springer Verlag, Singapore
ISBN:  

9789819538027

ISBN 10:   9819538025
Pages:   458
Publication Date:   03 January 2026
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print  
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Section XV  Topical calcineurin inhibitors.- Chapter 89  Tacrolimus and pimecrolimus.- Section XVI  Topical retinoids.- Chapter 90  Tretinoin.- Chapter 91  Tazarotene.- Chapter 92  Adapalene.- Chapter 93  Bexarotene.- Chapter 94  Trifarotene.- Section XVII  Topical glucocorticoids.- Chapter 95  Topical glucocorticoids.- Section XVIII  Topical antifungals.- Chapter 96  Azoles.- Chapter 97  Terbenafine.- Chapter 98  Butenafine.- Chapter 99  Naftifine.- Chapter 100  Tavaborole.- Chapter 101  Selenium sulphide.- Chapter 102  Ciclopirox.- Chapter 103  Amorolfine.- Chapter 104  Undecylenic acid.- Section XIX  Topical antiviral agents.- Chapter 105  Topical antiviral agents.- Section XX  Topical antibacterial agents.- Chapter 106  Mupirocin.- Chapter 107  Bacitracin.- Chapter 108  Clindamycin.- Chapter 109  Erythromycin.- Chapter 110  Neomycin.- Chapter 111  Polymyxin B.- Chapter 112  Retapamulin.- Chapter 113  Silver sulfadiazine.- Chapter 114  Metronidazole.- Chapter 115  Ozenoxazin.- Section XXI  Topical anti acne drugs.- Chapter 116  Benzoyl peroxide.- Chapter 117  Azelaic acid.- Section XXII  Topical agents for pediculosis and scabies.- Chapter 118  Permethrin.- Chapter 119  Spinosad.- Chapter 120  Malathion, Benzyl benzoate, Crotamiton, Lindane.- Chapter 121  Abametapir.- Section XXIII  Topical antipruritic agents.- Chapter 122  Capsaicin.- Chapter 123  Dephenhydramine.- Chapter 124  Doxepin.- Chapter 125  Menthol.- Chapter 126  Phenol.- Chapter 127  Pramoxine.- Section XXIV  Keratolytic agents.- Chapter 128  Salicylic acid.- Chapter 129  Sulfur.- Chapter 130  Urea.- Section XXV  Topical chemotherapeutic agents.- Chapter 131  5-FU.- Chapter 132  Bleomycin.- Chapter 133  Imiquimod (general).- Chapter 134  Imiquimod for malignant and pre-malignant conditions.- Chapter 135  Tirbanibulin.- Section XXVI  Topical vitamin D analogues.- Chapter 136  Topical vitamin D analogues.- Section XXVII  Topical skin lightening agents.- Chapter 137  Hydroquinone.- Chapter 138  Mequinol.- Chapter 139  MBEH.- Chapter 140  Cysteamine.- Section XXVIII  Sunscreens.- Chapter 141  Sunscreens.- Section XIX  Miscellaneous topical agents.- Chapter 142  Anthralin.- Chapter 143  Podophyllin.- Chapter 144  Tar.- Chapter 145  Cantharidin.- Chapter 146  Crisaborole.- Section XXX  EMLA.- Chapter 147  EMLA.- Section XXXI  Traditional therapies in dermatology.- Chapter 148  Traditional therapies in dermatology.- Section XXXII: Prostaglandin analogues.- Chapter 149  Latanoprost.- Chapter 150  Bimatoprost.- Section XXXIII  Chemical peels.- Chapter 151  Glycolic acid.- Chapter 152  Salicylic acid.- Chapter 153  Trichloroacetic acid.- Chapter 154  Lactic acid.- Chapter 155  Jessner’s peel.- Chapter 156  Mandelic acid.- Chapter 157  Pyruvic acid.- Chapter 158  Tretinoin.- Section XXXIV  Photodynamic therapy.- Chapter 159  Photodynamic therapy.- Section XXXV  Botulinum Toxin.- Chapter 160  Botulinum Toxin.

Reviews

Author Information

Dr. Aditya Kumar Bubna is a Dermatologist, currently working as an Associate Professor in the Department of Dermatology, Katihar Medical College, Katihar, India. He has more than 50 publications in national and international journals. His particular interest is dermatologic therapeutics, with a keen interest on various pharmacologic and therapeutic aspects of dermatologic drugs, both topical and systemic. He feels that a thorough knowledge in this regard assists in the introduction of innovative strategies, that can significantly aid in reducing the frequency of conventional drug administration, thereby helping in alleviating the prevalence of side effects. He further percieves that safety and efficacy of drugs go hand in hand, when it comes to treating patients, and a thorough knowledge of these drugs therefore becomes essential for all clinicians. His other interest in this field includes dermatopathology, an indispensable facet of diagnostic dermatology.

Tab Content 6

Author Website:  

Countries Available

All regions